One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. (Q34636998)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. |
scientific article |
Statements
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial (English)
Peter Hohenberger
Heikki Joensuu
Mikael Eriksson
Kirsten Sundby Hall
Jörg T Hartmann
Daniel Pink
Jochen Schütte
Giuliano Ramadori
Justus Duyster
Salah-Eddin Al-Batran
Marcus Schlemmer
Eva Wardelmann
Maarit Sarlomo-Rikala
Bengt Nilsson
Odd R Monge
Petri Bono
Raija Kallio
Mika Leinonen
Thor Alvegård
Peter Reichardt